{"id":"https://openalex.org/W4380029567","doi":"https://doi.org/10.1158/1538-7445.am2023-2283","title":"Abstract 2283: An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patients","display_name":"Abstract 2283: An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patients","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4380029567","doi":"https://doi.org/10.1158/1538-7445.am2023-2283"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-2283","doi":"https://doi.org/10.1158/1538-7445.am2023-2283","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2283","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072079484","display_name":"Ankita Mitra","orcid":"https://orcid.org/0000-0002-7368-1965","observed_orcids":["https://orcid.org/0000-0002-7368-1965"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankita Mitra","raw_affiliation_strings":["1NYU Langone Health, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NYU Langone Health, New York, NY;","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Thompson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Thompson","raw_affiliation_strings":["2University of Colorado School of Medicine, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado School of Medicine, Aurora, CO","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067364305","display_name":"David Michael Woods","orcid":"https://orcid.org/0000-0002-6328-8107","observed_orcids":["https://orcid.org/0000-0002-6328-8107"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Woods","raw_affiliation_strings":["2University of Colorado School of Medicine, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado School of Medicine, Aurora, CO","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047177507","display_name":"Jeffrey S. Weber","orcid":"https://orcid.org/0000-0002-4962-2957","observed_orcids":["https://orcid.org/0000-0002-4962-2957"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Weber","raw_affiliation_strings":["1NYU Langone Health, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NYU Langone Health, New York, NY;","institution_ids":["https://openalex.org/I4210086933"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"2283","last_page":"2283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.7089999914169312},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9710000157356262},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.6209999918937683},{"id":"https://openalex.org/keywords/ectonucleotidases","display_name":"ectonucleotidases","score":0.8180000185966492},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.7960000038146973},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5950000286102295},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8640000224113464},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.878000020980835},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.6259999871253967},{"id":"https://openalex.org/keywords/tox","display_name":"TOX","score":0.5979999899864197},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6097903847694397},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5890347957611084},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5726252198219299},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5409321784973145},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5094643235206604},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.502528190612793},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5021388530731201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49808764457702637},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4933439791202545},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4858507812023163},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46678388118743896},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4645891487598419},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4497353136539459},{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.4354996383190155},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.41895782947540283},{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.4177423119544983},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4101814329624176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31250178813934326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.210593581199646},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1475038230419159},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.07756638526916504},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06650969386100769},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.05665358901023865},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-2283","doi":"https://doi.org/10.1158/1538-7445.am2023-2283","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2283","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8100000023841858}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308399098","https://openalex.org/W3126655789","https://openalex.org/W4385330446","https://openalex.org/W4362594655","https://openalex.org/W4408326222","https://openalex.org/W3011956009","https://openalex.org/W2017752649","https://openalex.org/W3089517941","https://openalex.org/W2512255557","https://openalex.org/W4391905104"],"abstract_inverted_index":{"Abstract":[0],"The":[1,164,237],"development":[2],"of":[3,29,41,56,75,134,166,176,217,240,246,274,300,328,373,412],"antibodies":[4,31],"to":[5,26,58,63,86,110,130,234,319,338,369,401],"block":[6],"immune":[7,87,303,402],"checkpoints":[8],"like":[9],"PD-1,":[10],"CTLA-4,":[11,186],"PD-L1":[12],"or":[13,49,108],"LAG-3":[14],"has":[15,24,114],"been":[16],"a":[17,72,205,211,325,366],"major":[18],"advance":[19],"in":[20,91,214,228,283,305,333,344,358,375,405],"cancer":[21],"therapy.":[22,163],"This":[23,348],"led":[25],"the":[27,42,54,132,139,215,235,265,272,281,371,413],"approval":[28],"multiple":[30],"for":[32,416],"metastatic":[33,92,158,345,406],"melanoma":[34,93,159,285,346,377,407],"and":[35,70,100,126,137,148,188,192,222,277,336,354,425],"other":[36,284],"malignancies.":[37],"A":[38],"large":[39],"proportion":[40],"patients":[43,94,160,408],"do":[44],"not":[45],"benefit":[46],"from":[47,157],"CTLA-4":[48],"PD-1":[50],"antagonistic":[51],"antibodies.":[52],"Understanding":[53],"mechanisms":[55],"resistance":[57,318,343],"immunotherapy":[59,320,342,374],"is":[60,315,397],"thus":[61],"critical":[62],"improve":[64],"its":[65],"effectiveness.":[66],"Previously":[67],"we":[68,307],"identified":[69,324],"validated":[71],"novel":[73,326],"population":[74,168,327,349,396],"cells":[76,136,203,226,242,276,304,332,364],"characterized":[77],"by":[78,141,169,210],"phenotype":[79,133,195,353],"CD3+CD4+CD127-GARP-CD38+CD39+":[80,313,363],"that":[81,104,310],"was":[82],"associated":[83,248,316,340,398],"with":[84,230,249,264,280,317,341,399],"non-responsiveness":[85,400],"checkpoint":[88,403],"blockade":[89,404],"(ICB)":[90],"(Woods":[95],"et":[96],"al,":[97],"2020).":[98],"CD38":[99],"CD39":[101],"are":[102],"ectonucleotidases,":[103],"convert":[105],"intracellular":[106],"ATP":[107],"NADPH":[109],"extracellular":[111],"adenosine":[112],"which":[113],"suppressive":[115,206],"effect":[116],"on":[117,153,201,294],"T":[118,142,225,331,394],"cell":[119,143,395],"functions.":[120],"We":[121,269,323],"used":[122],"high-dimension":[123],"flow":[124,170,266],"cytometry":[125,267],"bulk":[127],"RNA":[128,297],"seq":[129,298],"characterize":[131],"these":[135,202,231,241,275],"evaluated":[138,271],"functions":[140],"suppression":[144],"assays.":[145],"All":[146],"characterizations":[147],"functional":[149,198],"experiments":[150],"were":[151],"performed":[152,200],"peripheral":[154,334],"blood":[155,335],"samples":[156],"undergoing":[161],"anti-PD1":[162],"characterization":[165],"this":[167],"cytomtery":[171],"shows":[172],"an":[173,193,244,311,351],"enhanced":[174],"expression":[175],"activation":[177],"markers":[178],"(4-1BB,":[179],"HLA-DR,":[180],"OX-40,":[181],"GITR),":[182],"inhibitory":[183],"receptors":[184],"(Tim3,":[185],"PD-1)":[187],"ligands":[189],"(PD-L1,":[190],"CD244)":[191],"exhausted":[194,352],"(TOXhiTCF1low).":[196],"Further":[197],"studies":[199],"showed":[204,243,350],"phenotype,":[207],"as":[208,256,258,365],"observed":[209],"significant":[212],"decrease":[213],"proliferation":[216,250],"target":[218,368],"autologous":[219,356],"CD4":[220],"(p=0.001)":[221],"CD8":[223],"(p=0.0012)":[224],"when":[227],"co-culture":[229],"cells,":[232],"compared":[233],"controls.":[236],"transcriptomic":[238],"features":[239],"upregulation":[245],"genes":[247],"(e.g.":[251,260],"CDC20,":[252],"TK1,":[253],"DHFR,":[254],"MYL6B),":[255],"well":[257],"exhaustion":[259],"upregulated":[261],"TOX),":[262],"consistent":[263],"data.":[268],"also":[270],"presence":[273],"their":[278],"correlation":[279],"outcome":[282],"datasets.":[286],"By":[287],"performing":[288],"gene":[289],"set":[290],"variation":[291],"analysis":[292],"(GSVA)":[293],"existing":[295],"single-cell":[296],"datasets":[299],"tumor":[301,337],"derived":[302],"melanoma,":[306],"have":[308],"found":[309],"intra-tumoral":[312],"signature":[314],"(p=":[321],"0.000003).":[322],"ectonucleotidase":[329],"expressing":[330],"be":[339],"patients.":[347,378],"suppressed":[355],"T-cells":[357],"vitro.":[359],"Our":[360],"data":[361],"identifies":[362],"potential":[367],"enhance":[370],"efficacy":[372],"advanced":[376],"Citation":[379],"Format:":[380],"Ankita":[381],"Mitra,":[382],"Brian":[383],"Thompson,":[384],"David":[385],"M.":[386],"Woods,":[387],"Jeffrey":[388],"S.":[389],"Weber.":[390],"An":[391],"immunosuppressive":[392],"ectoenzyme-expressing":[393],"[abstract].":[409],"In:":[410],"Proceedings":[411],"American":[414],"Association":[415],"Cancer":[417,436],"Research":[418],"Annual":[419],"Meeting":[420],"2023;":[421],"Part":[422],"1":[423],"(Regular":[424],"Invited":[426],"Abstracts);":[427],"2023":[428],"Apr":[429],"14-19;":[430],"Orlando,":[431],"FL.":[432],"Philadelphia":[433],"(PA):":[434],"AACR;":[435],"Res":[437],"2023;83(7_Suppl):Abstract":[438],"nr":[439],"2283.":[440]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-06-10T00:00:00"}